Dosage forms and methods of treatment using a tyrosine kinase inhibitor

Details for Australian Patent Application No. 2006293620 (hide)

Owner Pfizer Products Inc.

Inventors Gentile, Alfonso; Pithavala, Yazdi Kersi; Baum, Charles Michael; Brega, Nicoletta Maria

Agent Shelston IP

Pub. Number AU-A-2006293620

PCT Pub. Number WO2007/034327

Priority 60/719,119 20.09.05 US

Filing date 12 September 2006

Wipo publication date 29 March 2007

International Classifications

A61K 31/5377 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/034327 Priority application(s): WO2007/034327

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006293625-Process for separating solutes and water from aqueous solutions with gas recycling

2006293619-Imidazole compounds for the treatment of neurological disorders